1.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor:
Protocol IDs: EORTC-30972, BMS-CA142-025
|
|
2.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: BMS-CA142-029
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GPC SAT3-03-01, NCT00069745
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-16942N
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAN-NCIC-IND102, BMS-182751, IND102
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: Protocol 05-021, NCT00265655
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SAT2-05-05, NCT00268970
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 70 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SAT2-05-07, NCT00370383
|
|
9.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 080074, 08-C-0074, NCI-08-C-0074, NCI-P07140, NCT00634647
|
|
10.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND85, NCI-V94-0557, IND85
|
|
11.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAN-NCIC-IND96, BMS-CA142-016, BMS-CAN-NCIC-IND96, NCI-V96-1065, IND96
|
|
12.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000518085, P30CA022453, WSU-2006-118, NCT00499694
|
Mobile | Español
